Plain-English translation of NCT06109493 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a form of psychological therapy called ACT (Acceptance and Commitment Therapy) can help people with chronic kidney disease who are on dialysis and dealing with depression. ACT is a talking therapy that teaches you ways to cope with difficult emotions and live a more meaningful life. The study will measure whether this treatment improves mood and overall well-being over time.
People with chronic kidney disease on dialysis often struggle with depression, which can make managing their illness harder and affect their quality of life. This trial is testing whether this therapy can provide real relief and support for patients facing both a serious physical illness and emotional challenges.
You likely qualify if…
You likely don't qualify if…
If you are assigned to the treatment group, you will attend 8 individual therapy sessions with a trained therapist over 8 weeks, where you will learn and practice ACT techniques. You will complete brief questionnaires before treatment starts, after the 8 sessions end, and again 3 months later to see how you are doing. If you are assigned to the waiting list group, you will wait 5 months and then receive the same treatment.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Spain
Sponsor
Universidad Europea de Madrid
Collaborators
Fundación Renal Iñigo Alvarez De Toledo, Centro de Enseñanza Superior Cardenal Cisneros
Enrollment target
~104 participants
Started
November 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Francisco Montesinos, Ph.D.
Universidad Europea de Madrid
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.